Point of Care Infectious Disease Testing Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: Alere, Thermo Fisher Scientific, F. Hoffmann-La Roche, Siemens Healthineers

The global Point of Care Infectious Disease Testing market reached a value of US$ 1.9 billion in 2021. Looking ahead, the market is expected to reach $ 4.2 billion by 2027, growing at a CAGR of 17.8% between 2022 and 2027.

Point of Care Infectious Disease Testing Market Overview

Infectious diseases are caused by pathogenic microorganisms such as bacteria, parasites, viruses, and fungus. It may transfer from one person to another directly or inadvertently. Some of the typical signs and symptoms of infectious disorders include fever, muscle aches, diarrhea, and weariness. The infection-causing organism will influence how these symptoms develop. Vaccination can prevent the spread of several illnesses, including measles and chicken pox. Drugs that are antibacterial, antifungal, and antiparasitic are used to treat them.

POC testing facilitates quicker identification of infectious diseases close to the patient site and provides prompt results. Multiplex point-of-care diagnostic technology development is now the attention of several researchers. These MPOCT devices use bead technology, array settings, hybridization sheets, or microfluidic systems to shorten the number of test steps and deliver diagnosis results in 15–30 minutes. The introduction of new technologies has changed testing's accuracy, usability, and speed. In order to maximize market potential during the predicted period, it is anticipated that there will be an increase in the number of possibilities to investigate how to quicken the development of POC testing in the infectious illness POC diagnostics market.

The prevalence of diseases including HIV, influenza, RSV, and others is rising globally, which increases the rate at which patients are diagnosed. Owing to advantages such as quick turnaround time and the ability to make immediate treatment decisions, POC diagnosis has become a crucial part of patient-centric healthcare. There has been a preferential shift from centralized to decentralized point of care testing for infectious diseases, leading to improved patient care. The growing demand for rapid tests has encouraged the market players to supply POC products to decentralized locations, thereby driving this market. 

Industry News and Updates:

January 19, 2022: Chembio Announces U.S. Commercial Launch of Diagnostic Tool to Differentiate COVID-19 and Flu --

In-licensed Rapid Point-of-Care Test Available for Use in Detecting COVID-19 Antigens, Flu A and Flu B from a Single Patient Sample in 15 Minutes. Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced the commercial launch of an FDA Emergency Use Authorization-approved, in-licensed rapid point-of-care COVID-19/Flu A&B test, for use in decentralized and traditional testing settings. Product inventory is on-hand and immediately available for shipment to customers across the United States.

What are the major Applications, Types and Regions for Point of Care Infectious Disease Testing Market?

Market is segmented based on the type, applications, companies and regions.

By Type, it is segmented into

• HIV POC


• HBV POC


• Pneumonia or Streptococcus Associated Infections


• Respiratory Syncytial Virus (RSV) POC


• HPV POC


• Influenza POC


• Others

By Application, it is segmented into

• Hospitals


• Clinics


• Home


• Others

Point of Care Infectious Disease Testing Market Regional Analysis

A growing frequency of infectious diseases in the region has led to North America dominating the global market for point-of-care infectious disease diagnostics. In this industry, substantial growth rates in Asia are anticipated during the next five years. The fastest-growing markets in the region are anticipated to be those in China and India. Due to increased R&D efforts and newer goods, Europe, which had the second-largest market share, is anticipated to have rapid growth. The Asia Pacific market will grow at a faster rate due to growing market penetration and rising adoption of point-of-care diagnostics kits. Additionally, market participants in this region are investing heavily, which will increase demand for cutting-edge goods.

Due to a lack of understanding within the healthcare community and the benefits of point-of-care diagnosis, Latin America and the Middle East and Africa accounted for a significantly lower part of the market.

• North America
  
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East & Africa
  
  
  • Latin America
  
  
  
  

The Point of Care Infectious Disease Testing Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Point of Care Infectious Disease Testing Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

What is our Point of Care Infectious Disease Testing Market report scope?

Key Takeaways from this Point of Care Infectious Disease Testing Market Report

• Evaluate Point of Care Infectious Disease Testing market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.


• Understand the different dynamics influencing the market - growth driving factors, specific challenges and hidden opportunities.


• Get in-depth insights on your competitor performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis and more.


• Analyze the sales and distribution channels across geographies to enhance top-line revenues.


• Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies in your processes.


• Get a quick outlook on the Point of Care Infectious Disease Testing market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.


• Evaluate the import-export statistics, supply-demand and competitive landscape for more than top 20 countries globally for the market.

Frequently Asked Questions

What is the growth rate of Point of Care Infectious Disease Testing Market?

The Point of Care Infectious Disease Testing Market is growing at a CAGR of 17.8% over the next 5 years.

Who are the key players in Point of Care Infectious Disease Testing Market?

Alere, Thermo Fisher Scientific, F. Hoffmann-La Roche, Siemens Healthineers, BD, Chembio Diagnostics, Trinity Biotech, Cardinal Health, Quest Diagnostics, Bio-Rad Labs, bioMérieux, Sight Diagnostics, Gene POC, Trivitron Healthcare, OJ-Bio, Ortho-Clinical Diagnostics, Abbott Laboratories, Quest Diagnostics Incorporated, bioMérieux SA, Cardinal Health, Inc., Mesa Biotech, Cepheid, Quidel Corporation

What are the significant types of Point of Care Infectious Disease Testing Market?

HIV POC, HBV POC, Pneumonia or Streptococcus Associated Infections, Respiratory Syncytial Virus (RSV) POC, HPV POC, Influenza POC, Others

What are the major end-use applications of Point of Care Infectious Disease Testing Market?

Hospitals, Clinics, Home, Others

All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.